AP2013007057A0 - (5S,8S)-3-(4'chlor-3'-fluor-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one(compound A)for treatment - Google Patents

(5S,8S)-3-(4'chlor-3'-fluor-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one(compound A)for treatment

Info

Publication number
AP2013007057A0
AP2013007057A0 AP2013007057A AP2013007057A AP2013007057A0 AP 2013007057 A0 AP2013007057 A0 AP 2013007057A0 AP 2013007057 A AP2013007057 A AP 2013007057A AP 2013007057 A AP2013007057 A AP 2013007057A AP 2013007057 A0 AP2013007057 A0 AP 2013007057A0
Authority
AP
ARIPO
Prior art keywords
methylbiphenyl
azaspiro
chlor
fluor
methoxy
Prior art date
Application number
AP2013007057A
Other languages
English (en)
Inventor
Knut Eis
Ningshu Liu
Maher Najjar
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102011011040A external-priority patent/DE102011011040A1/de
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of AP2013007057A0 publication Critical patent/AP2013007057A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54—Spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AP2013007057A 2011-02-06 2012-02-03 (5S,8S)-3-(4'chlor-3'-fluor-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one(compound A)for treatment AP2013007057A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KW1411 2011-02-06
DE102011011040A DE102011011040A1 (de) 2011-02-08 2011-02-08 (5s,8s)-3-(4'-Chlor-3'-fluor-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-on (Verbindung A) zur Therapie
PCT/EP2012/051895 WO2012104428A1 (de) 2011-02-06 2012-02-03 (5s,8s)-3-(4'-chlor-3'-fluor-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-on (verbindung a) zur therapie

Publications (1)

Publication Number Publication Date
AP2013007057A0 true AP2013007057A0 (en) 2013-08-31

Family

ID=49485835

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013007057A AP2013007057A0 (en) 2011-02-06 2012-02-03 (5S,8S)-3-(4'chlor-3'-fluor-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one(compound A)for treatment

Country Status (18)

Country Link
US (1) US9212140B2 (es)
EP (1) EP2670408A1 (es)
JP (1) JP2014504624A (es)
KR (1) KR20140053844A (es)
CN (1) CN103533932A (es)
AP (1) AP2013007057A0 (es)
AR (1) AR085146A1 (es)
AU (1) AU2012213344A1 (es)
BR (1) BR112013020015A2 (es)
CA (1) CA2826515A1 (es)
CL (1) CL2013002247A1 (es)
EA (1) EA201391084A1 (es)
IL (1) IL227804A0 (es)
MA (1) MA34887B1 (es)
MX (1) MX2013009065A (es)
TN (1) TN2013000336A1 (es)
TW (1) TW201240659A (es)
WO (1) WO2012104428A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2923884A1 (en) 2013-09-12 2015-03-19 Pfizer Inc. Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507275A (pt) * 1994-04-05 1997-11-18 Bayer Ag 1h-3-aril-pirrolidina-2,4-dionas alcoxi-alquil-substituídas
DE19813354A1 (de) * 1998-03-26 1999-09-30 Bayer Ag Arylphenylsubstituierte cyclische Ketoenole
DE10201239A1 (de) * 2002-01-15 2003-07-24 Bayer Cropscience Ag Fungizide biphenylsubstituierte cyclische Ketoenole
DE102006057037A1 (de) * 2006-12-04 2008-06-05 Bayer Cropscience Ag cis-Alkoxyspirocyclische biphenylsubstituierte Tetramsäure-Derivate
UY31968A (es) * 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
DE102010008644A1 (de) * 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 Zyklische Ketoenole zur Therapie

Also Published As

Publication number Publication date
KR20140053844A (ko) 2014-05-08
TW201240659A (en) 2012-10-16
MA34887B1 (fr) 2014-02-01
BR112013020015A2 (pt) 2017-03-21
EP2670408A1 (de) 2013-12-11
AU2012213344A1 (en) 2013-08-22
CN103533932A (zh) 2014-01-22
CL2013002247A1 (es) 2014-01-03
EA201391084A1 (ru) 2014-02-28
US9212140B2 (en) 2015-12-15
CA2826515A1 (en) 2012-08-09
JP2014504624A (ja) 2014-02-24
TN2013000336A1 (en) 2015-01-20
AR085146A1 (es) 2013-09-11
MX2013009065A (es) 2013-10-01
US20140031407A1 (en) 2014-01-30
WO2012104428A1 (de) 2012-08-09
IL227804A0 (en) 2013-09-30

Similar Documents

Publication Publication Date Title
HUS2000040I1 (hu) Fungicid szubsztituált 2-[2.halogénalkil-4-(fenoxi-fenil]-1-[1,2,4]triazol-1-il-etanol vegyületek
HK1193091A1 (en) Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3- en-2-ones for therapy 3-(-3-)-88--4--1-[45]-3--2-
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
AP3884A (en) 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
EP2681216A4 (en) SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS CONDENSED IN 6.5
AP3589A (en) A novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes
PL2531505T3 (pl) Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami
EP2576488A4 (en) PROCESS FOR PRODUCING CIS-1,1,1,4,4,4, -HEXAFLUORO-2-BUTENE
HK1198586A1 (zh) -二氟甲基- -二氫- 噁嗪- -胺衍生物
HK1201150A1 (en) Scheme for administering n-hydroxy-4-2-[3-(n,n- dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxybenzamide n--4-2-[3-(n,n-)-2-]
AU2012216866A1 (en) Haymaking machine
HK1203501A1 (en) 2 - (pyridin- 2yl) - 1, 7 -diaza-spiro [4.4]nonane- 6 -one compound as voltage-gated sodium channels modulator 2-(-2 )-17-[44]-6-
IL232194A0 (en) An improved iontophoretic cross-linking mixture for use in the treatment of keratoconus
EP2883870B8 (en) Method for producing 1,4-benzoxazine compound
IL222133A (en) Diacrine or its common pharmacy salt, monoacetylarine or Rin, for use as a supplement for type II diabetes
EP2634183B8 (en) Method for preparing 1,3,5-trioxane
IL227804A0 (en) S8,s5))-3-(4'-chloro-3'-fluoro-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2- On (compound a) for treatment
PL2771328T3 (pl) Sposób otrzymywania 1,2-benzizotiazolin-3-onu
WO2011137376A9 (en) Compounds for anti-fungal treatment
PL390164A3 (pl) Urządzenie do zraszania, zwłaszcza powietrzno-wodnego
PL2531504T3 (pl) Sposób wytwarzania roztworów kompleksów metali z 3,7-diazabicyklo[3.3.1]nonanem
IL222929A0 (en) Process for preparing substituted 1, 3 - dihydro - 2h - indol - 2 - ones
AU2010904048A0 (en) Easy as a, b send
EP2627655A4 (en) THERAPEUTIC 5,6,5-TRICYCLIC ANALOGUES
AU2011904559A0 (en) Ctshws500/2.7